• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用羟基酰胺内酯化的胺类前药。I. 一种潜在的氧化还原敏感酰胺前药。

Amine prodrugs which utilize hydroxy amide lactonization. I. A potential redox-sensitive amide prodrug.

作者信息

Amsberry K L, Borchardt R T

机构信息

Department of Pharmaceutical Chemistry, University of Kansas, Lawrence 66045.

出版信息

Pharm Res. 1991 Mar;8(3):323-30. doi: 10.1023/a:1015885213625.

DOI:10.1023/a:1015885213625
PMID:2052518
Abstract

Several amides of 3-(3',6'-dioxo-2',4'-dimethylcyclohexa-1',4'-diene)-3,3- dimethylpropionic acid (2) have been synthesized and tested as model redox-sensitive pro-prodrugs of amines. The reduction of these model pro-prodrugs generated hydroxy amide intermediates 4a-4h, the lactonization of which resulted in amine release. The rates of lactonization of 4a-4h were investigated at pH 7.4 and 37 degrees C. The half-lives for appearance of the product lactone 1a from these intermediates were found to range from 1.4 to 3.4 min. With such rapid lactonization rates, it is believed that reduction will be the rate-limiting step in the two-step conversion of the pro-prodrug to the amine.

摘要

已合成了几种3-(3',6'-二氧代-2',4'-二甲基环己-1',4'-二烯)-3,3-二甲基丙酸(2)的酰胺,并作为胺类的模型氧化还原敏感前药进行了测试。这些模型前药的还原产生了羟基酰胺中间体4a-4h,其内酯化导致胺的释放。在pH 7.4和37℃下研究了4a-4h的内酯化速率。发现这些中间体生成产物内酯1a的半衰期为1.4至3.4分钟。由于内酯化速率如此之快,据信还原将是前药两步转化为胺的限速步骤。

相似文献

1
Amine prodrugs which utilize hydroxy amide lactonization. I. A potential redox-sensitive amide prodrug.利用羟基酰胺内酯化的胺类前药。I. 一种潜在的氧化还原敏感酰胺前药。
Pharm Res. 1991 Mar;8(3):323-30. doi: 10.1023/a:1015885213625.
2
Amine prodrugs which utilize hydroxy amide lactonization. II. A potential esterase-sensitive amide prodrug.
Pharm Res. 1991 Apr;8(4):455-61. doi: 10.1023/a:1015890809507.
3
Coumarin-based prodrugs. Part 3: Structural effects on the release kinetics of esterase-sensitive prodrugs of amines.香豆素类前药。第3部分:胺类酯酶敏感前药释放动力学的结构效应。
Bioorg Med Chem. 1998 Apr;6(4):417-26. doi: 10.1016/s0968-0896(98)00014-5.
4
Synthesis and stability study of a modified phenylpropionic acid linker-based esterase-sensitive prodrug.一种基于修饰苯丙酸连接子的酯酶敏感前药的合成与稳定性研究
Bioorg Med Chem Lett. 2002 Dec 2;12(23):3439-42. doi: 10.1016/s0960-894x(02)00750-3.
5
Facilitated Intramolecular Conjugate Addition of Amides of 3-(3',6'-Dioxo-2',4'-dimethyl-1',4'-cyclohexadienyl)-3,3-dimethylpropionic Acid. 2. Kinetics of Degradation.3-(3',6'-二氧代-2',4'-二甲基-1',4'-环己二烯基)-3,3-二甲基丙酸酰胺的分子内共轭加成反应。2. 降解动力学
J Org Chem. 1996 Sep 20;61(19):6633-6638. doi: 10.1021/jo961069l.
6
Prodrugs of peptides. 13. Stabilization of peptide amides against alpha-chymotrypsin by the prodrug approach.
Pharm Res. 1991 Dec;8(12):1533-8. doi: 10.1023/a:1015854718903.
7
Relationships between structure and kinetics of cyclization of 2-aminoaryl amides: potential prodrugs of cyclization-activated aromatic mustards.
J Med Chem. 1994 Feb 4;37(3):371-80. doi: 10.1021/jm00029a009.
8
Novel prodrug approach for tertiary amines: synthesis and preliminary evaluation of N-phosphonooxymethyl prodrugs.叔胺的新型前药方法:N-膦酰氧基甲基前药的合成与初步评价
J Med Chem. 1999 Aug 12;42(16):3094-100. doi: 10.1021/jm980539w.
9
Prodrug strategies based on intramolecular cyclization reactions.基于分子内环化反应的前药策略。
J Pharm Sci. 1997 Jul;86(7):765-7. doi: 10.1021/js970069d.
10
N-Substituted 2-(2,6-dinitrophenylamino)propanamides: novel prodrugs that release a primary amine via nitroreduction and intramolecular cyclization.
J Med Chem. 1999 Feb 11;42(3):346-55. doi: 10.1021/jm960783s.

引用本文的文献

1
Detection of DT-diaphorase Enzyme with a ParaCEST MRI Contrast Agent.使用一种顺磁化学交换饱和转移(ParaCEST)磁共振成像(MRI)造影剂检测DT-黄递酶
Chemistry. 2017 May 11;23(27):6514-6517. doi: 10.1002/chem.201700721. Epub 2017 Apr 20.
2
Hypoxic tumor microenvironment: Opportunities to develop targeted therapies.缺氧肿瘤微环境:开发靶向治疗的机遇
Biotechnol Adv. 2016 Sep-Oct;34(5):803-812. doi: 10.1016/j.biotechadv.2016.04.005. Epub 2016 Apr 30.
3
Esterase-Sensitive Prodrugs with Tunable Release Rates and Direct Generation of Hydrogen Sulfide.

本文引用的文献

1
The effect of tissue oxygen tension on the radiosensitivity of leukaemia cells irradiated in situ in the livers of leukaemic mice.组织氧张力对白血病小鼠肝脏原位照射的白血病细胞放射敏感性的影响。
Br J Cancer. 1959 Dec;13(4):675-84. doi: 10.1038/bjc.1959.75.
2
MITOMYCINS AND PORFIROMYCIN: CHEMICAL MECHANISM OF ACTIVATION AND CROSS-LINKING OF DNA.丝裂霉素和卟吩姆:DNA激活与交联的化学机制
Science. 1964 Jul 3;145(3627):55-8. doi: 10.1126/science.145.3627.55.
3
MITOMYCIN C: CHEMICAL AND BIOLOGICAL STUDIES ON ALKYLATION.丝裂霉素C:烷基化的化学与生物学研究
具有可调释放速率和直接生成硫化氢功能的酯酶敏感前药
Angew Chem Int Ed Engl. 2016 Mar 24;55(14):4514-8. doi: 10.1002/anie.201511244. Epub 2016 Jan 28.
4
Lipid nature and their influence on opening of redox-active liposomes.脂质的性质及其对氧化还原活性脂质体开放的影响。
Langmuir. 2013 Jun 4;29(22):6615-23. doi: 10.1021/la304340e. Epub 2013 May 22.
5
Trimethyl lock: A trigger for molecular release in chemistry, biology, and pharmacology.三甲基锁:化学、生物学和药理学中分子释放的触发因素。
Chem Sci. 2012 Jan 1;3(8):2412-2420. doi: 10.1039/C2SC20536J. Epub 2012 May 30.
6
Chemical syntheses and in vitro antibacterial activity of two desferrioxamine B-ciprofloxacin conjugates with potential esterase and phosphatase triggered drug release linkers.两种去铁胺 B-环丙沙星缀合物的化学合成及体外抗菌活性,具有潜在的酯酶和磷酸酶触发的药物释放连接物。
Bioorg Med Chem. 2012 Jun 15;20(12):3828-36. doi: 10.1016/j.bmc.2012.04.034. Epub 2012 May 2.
7
A self-calibrating PARACEST MRI contrast agent that detects esterase enzyme activity.一种自校准的 PARACEST MRI 对比剂,可检测酯酶酶活性。
Contrast Media Mol Imaging. 2011 Jul-Aug;6(4):219-28. doi: 10.1002/cmmi.421. Epub 2010 Nov 30.
8
Prodrugs for amines.胺类前药。
Molecules. 2008 Mar 3;13(3):519-47. doi: 10.3390/molecules13030519.
9
Cyclization-activated prodrugs.环化激活前药
Molecules. 2007 Nov 12;12(11):2484-506. doi: 10.3390/12112484.
10
Esterase-sensitive cyclic prodrugs of peptides: evaluation of a phenylpropionic acid promoiety in a model hexapeptide.肽的酯酶敏感型环状前药:模型六肽中苯丙酸部分的评估
Pharm Res. 1997 Jan;14(1):11-7. doi: 10.1023/a:1012091014242.
Science. 1963 Nov 29;142(3596):1181-3. doi: 10.1126/science.142.3596.1181.
4
Pharmacology of mitomycin C. III. In vitro metabolism by rat liver.
J Pharmacol Exp Ther. 1962 May;136:250-8.
5
Radiobiologic basis of oxygen as a modifying factor in radiation therapy.氧作为放射治疗中修饰因子的放射生物学基础。
Am J Roentgenol Radium Ther Nucl Med. 1961 May;85:803-15.
6
Pro-drugs of amides, imides, and amines.酰胺、酰亚胺和胺的前体药物。
Med Res Rev. 1981 Summer;1(2):189-214. doi: 10.1002/med.2610010204.
7
Sulindac: therapeutic implications of the prodrug/pharmacophore equilibrium.舒林酸:前药/药效基团平衡的治疗意义。
Drug Metab Rev. 1981;12(2):325-37. doi: 10.3109/03602538108994035.
8
The hypoxic tumor cell: a target for selective cancer chemotherapy.缺氧肿瘤细胞:选择性癌症化疗的靶点。
Biochem Pharmacol. 1980 Jan 1;29(1):1-8. doi: 10.1016/0006-2952(80)90235-x.
9
The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour.移植的小鼠乳腺肿瘤中细胞增殖与血管系统之间的关系。
Br J Cancer. 1968 Jun;22(2):258-73. doi: 10.1038/bjc.1968.34.
10
Stereopopulation control. 3. Facilitation of intramolecular conjugate addition of the carboxyl group.立体种群控制。3. 羧基分子内共轭加成的促进作用。
J Am Chem Soc. 1972 Dec 27;94(26):9175-82. doi: 10.1021/ja00781a031.